Video Latest - ecancer

Global drug pricing: How cost-effective is bevacizumab?

Dr Daniel Goldstein - Emory University, Atlanta, USA

6 Jun 2016

Trial of proposed trastuzumab biosimilar, MYL-1401O vs herceptin

Dr Hope Rugo - University of California, San Francisco, USA

3 Jun 2016

Randomised double blind phase III safety and efficacy trial of the proposed trastuzumab biosimilar, MYL-1401O vs. herceptin

Dr Hope Rugo - University of California, San Francisco, USA

3 Jun 2016

Oncology for children: what can be done when resources are scarce?

Prof Elizabeth Molyneux - Queen Elizabeth Central Hospital, Blantyre, Malawi

6 May 2016

Radiotherapy in Hogkin lymphoma: reducing risk in later life

Dr Graham Collins - Oxford University Hospitals NHS Foundation Trust, Oxford, UK

6 May 2016

First outcome results from MINDACT breast cancer clinical trial

Dr Martine Piccart - Jules Bordet Institute, Brussels, Belgium

6 May 2016

Integrating multiple omics information in the era of precision oncology

Dr Yu Shyr - Vanderbilt-Ingram Cancer Center, Nashville, USA

5 May 2016

Inflammatory microenvironment regulates colorectal cancer progression

Dr Sergei Grivennikov - Fox Chase Cancer Center, Philadelphia, USA

4 May 2016

Innovations in assessing patient outcomes

Dr Heather Jim - Moffitt Cancer Center, Tampa, USA

3 May 2016

Technologies for personalised cancer immunotherapies

Prof James Heath - California Institute of Technology, Pasadena, USA

3 May 2016

Clinical cases employing novel agents in Hodgkin lymphoma

Dr Craig Moskowitz - Memorial Sloan Kettering Cancer Centre, New York, USA

29 Apr 2016

Current trials in chronic lymphocytic leukaemia

Dr George Follows - Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK

29 Apr 2016

Video